Journal of the American Society of Nephrology, Vol 9, 310-313, Copyright © 1998 by American Society of Nephrology

REGULAR ARTICLES

Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease

F Gaspari, N Perico, M Matalone, O Signorini, N Azzollini, M Mister and G Remuzzi
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

The choice of the optimal method for the measurement of renal function is based on the accuracy and the precision of the technique. The plasma clearance of nonradioactive iohexol has been proposed as a reliable alternative to renal clearance of inulin for estimation of GFR. However, the precision of this method in estimating GFR in patients with renal disease has not been determined so far. This issue was assessed by determining plasma clearance of iohexol on three different occasions during a 12-d period in 24 patients with renal disease and a wide range of renal function (creatinine clearance: 14 to 104 ml/min per 1.73 m2). Overall, the mean intraindividual coefficient of variation was 5.59%, and the reproducibility was 6.28%. The precision of the method also applied to the subgroup of patients with moderate-to- severe renal insufficiency, because a low coefficient of variation (5.71%) and a high reproducibility (6.57%) were found in patients with GFR < or =40 ml/min per 1.73 m2. It was also shown that the precision of GFR measurement by the plasma clearance of iohexol is not affected by the gender. These findings indicate that the method of plasma clearance of iohexol allows a good precision in the estimation of GFR in patients with normal renal function and different degrees of renal dysfunction.

This article has been cited by other articles:

				L. A. Stevens and A. S. Levey Measured GFR as a Confirmatory Test for Estimated GFR J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2305 - 2313. [Abstract] [Full Text] [PDF]

				M. Mauer, B. Zinman, R. Gardiner, S. Suissa, A. Sinaiko, T. Strand, K. Drummond, S. Donnelly, P. Goodyer, M. C. Gubler, et al. Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes N. Engl. J. Med., July 2, 2009; 361(1): 40 - 51. [Abstract] [Full Text] [PDF]

				M. M. Tavakol, F. G. Vincenti, H. Assadi, M. J. Frederick, S. J. Tomlanovich, J. P. Roberts, and A. M. Posselt Long-Term Renal Function and Cardiovascular Disease Risk in Obese Kidney Donors Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1230 - 1238. [Abstract] [Full Text] [PDF]

				A M. Peters, N. J Bird, I. Halsall, C. Peters, and A R. Michell Evaluation of the Modification of Diet in Renal Disease equation (eGFR) against simultaneous, dual-marker multi-sample measurements of glomerular filtration rate Ann Clin Biochem, January 1, 2009; 46(1): 58 - 64. [Abstract] [Full Text] [PDF]

				N. J Bird, C. Peters, A R. Michell, and A M. Peters Reproducibilities and responses to food intake of GFR measured with chromium-51-EDTA and iohexol simultaneously and independently in normal subjects Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1902 - 1909. [Abstract] [Full Text] [PDF]

				K.-S. Spanaus, F. Kronenberg, E. Ritz, R. Schlapbach, D. Fliser, M. Hersberger, B. Kollerits, P. Konig, A. von Eckardstein, and for the Mild-to-Moderate Kidney Disease Study Grou B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study Clin. Chem., July 1, 2007; 53(7): 1264 - 1272. [Abstract] [Full Text] [PDF]

				J. Traynor, R. Mactier, C. C Geddes, and J. G Fox How to measure renal function in clinical practice. BMJ, October 7, 2006; 333(7571): 733 - 737. [Full Text] [PDF]

				L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey Assessing kidney function--measured and estimated glomerular filtration rate. N. Engl. J. Med., June 8, 2006; 354(23): 2473 - 2483. [Full Text] [PDF]

				D. Fliser, F. Kronenberg, J. T. Kielstein, C. Morath, S. M. Bode-Boger, H. Haller, and E. Ritz Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease Study J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2456 - 2461. [Abstract] [Full Text] [PDF]

				B. Becker, F. Kronenberg, J. T. Kielstein, H. Haller, C. Morath, E. Ritz, D. Fliser, and for the MMKD Study Group Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1091 - 1098. [Abstract] [Full Text] [PDF]

				E. Gotti, N. Perico, A. Perna, F. Gaspari, D. Cattaneo, R. Caruso, S. Ferrari, N. Stucchi, G. Marchetti, M. Abbate, et al. Renal Transplantation: Can We Reduce Calcineurin Inhibitor/Stop Steroids? Evidence Based on Protocol Biopsy Findings J. Am. Soc. Nephrol., March 1, 2003; 14(3): 755 - 766. [Abstract] [Full Text] [PDF]

				M. Mauer, B. Zinman, R. Gardiner, K. N Drummond, S. Suissa, S. M Donnelly, T. D Strand, M. S Kramer, R. Klein, and A. R Sinaiko ACE-I and ARBs in early diabetic nephropathy Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 262 - 269. [Abstract] [PDF]

				A. G. Bostom, F. Kronenberg, and E. Ritz Predictive Performance of Renal Function Equations for Patients with Chronic Kidney Disease and Normal Serum Creatinine Levels J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2140 - 2144. [Abstract] [Full Text] [PDF]

				F. Kronenberg, E. Kuen, E. Ritz, P. Konig, G. Kraatz, K. Lhotta, J. F. E. Mann, G. A. Muller, U. Neyer, W. Riegel, et al. Apolipoprotein A-IV Serum Concentrations Are Elevated in Patients with Mild and Moderate Renal Failure J. Am. Soc. Nephrol., February 1, 2002; 13(2): 461 - 469. [Abstract] [Full Text] [PDF]

				F. KRONENBERG, E. KUEN, E. RITZ, R. JUNKER, P. KÖNIG, G. KRAATZ, K. LHOTTA, J. F. E. MANN, G. A. MÜLLER, U. NEYER, et al. Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure J. Am. Soc. Nephrol., January 1, 2000; 11(1): 105 - 115. [Abstract] [Full Text]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673